Clinical Trial Update: Extension Study on Safety and Rebound Effect of SAT-001 for Myopia in Children

View source ↗

Summary

An extension study is evaluating the safety and rebound effects of SAT-001 for myopia in children. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• SAT-001

Snippet

Sponsor: S-Alpha Therapeutics, Inc. | Conditions: Myopia | Status: RECRUITING